Overview

Lifesaving Vision

If your child or teenager's condition requires a bone-marrow transplant, you should know that the Fred Hutchinson Transplant program at SCCA was ranked first in outcomes in a four-year study by the National Marrow Donor Program (NMDP) that measured one-year survival rates of patients among 122 transplant centers in the United States. The Hutchinson Center pioneered the use of bone-marrow transplants as a treatment for blood diseases over 40 years ago. Since then thousands of patients with leukemia have come from around the world to receive bone-marrow transplants at SCCA. Bone-marrow transplants have transformed leukemia and related cancers, once thought incurable, into highly treatable diseases with survival rates as high as 80 percent.

You may also want to read about our Pediatric Bone-Marrow Transplant Success Rates.

During the treatment period for bone-marrow transplantation, your child's treatment will take place at Seattle Children's by a highly trained and knowledgeable medical team that understands the application of research-based therapies and the care needed for pediatric patients undergoing bone-marrow transplantation.